Organon, Inc. v. Hepler

595 P.2d 1314, 23 Wash. App. 432, 1979 Wash. App. LEXIS 2338
CourtCourt of Appeals of Washington
DecidedMay 29, 1979
Docket2910-3
StatusPublished
Cited by9 cases

This text of 595 P.2d 1314 (Organon, Inc. v. Hepler) is published on Counsel Stack Legal Research, covering Court of Appeals of Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Organon, Inc. v. Hepler, 595 P.2d 1314, 23 Wash. App. 432, 1979 Wash. App. LEXIS 2338 (Wash. Ct. App. 1979).

Opinion

*433 Green, C.J.

The defendant appeals from a directed verdict and an award of damages in favor of the plaintiff, Organon, Inc. Two issues are presented: (1) Did the trial court err when it decided, as a matter of law, that the defendant had breached his agreement with Organon to refrain from outside business activities while employed by that company? and (2) Did the trial court err when it awarded Organon damages in the absence of any showing that Organon had lost profits as a result of the defendant's breach? We affirm.

In reviewing a directed verdict, the appellate court looks to see whether any evidence or reasonable inference therefrom supports the position of the losing party. Wold v. Jones, 60 Wn.2d 327, 329, 373 P.2d 805 (1957). The testimony here was undisputed. When the defendant went to work for Organon as a drug salesman in 1968, he signed the following "Statement of Policy":

The ethical pharmaceutical business is an exacting business and requires the full-time effort of those of us who have chosen this field of endeavor. There is much to learn, as it is necessary for all of us to acquire a medical vocabulary, know medical terminology, have a working knowledge of physiology, know anatomy, chemistry and the chemicals that are a part of the products we are promoting.
The ethical pharmaceutical business is an ever-changing business. All the functions of the human body and the action of all drugs and chemicals is not thoroughly understood. Research brings us many new discoveries each year, better understanding of the human body, more knowledge of drugs and chemicals. We in this industry must keep up with this progress. We must constantly read and study so that we have knowledge of these new developments.
Thus, in order to allow you plenty of time for such reading and studying, Organon's policy must necessarily prohibit members of the field staff from engaging in any outside business activities whatsoever for financial gain, such as moonlighting in any way, working at a part-time job in the evening and/or on weekends, selling products, services or merchandise of any type or kind, selling *434 insurance, subscriptions, real estate or any other commodity of any type or kind whatsoever.
In light of the foregoing, you can understand why we must consider immediate dismissal of an Organon Representative who engages in such activities for financial gain.
I Have Read and Understand the Foregoing Statements.
/s/ Brian P. Hepler_
Representative
1/11/68_
Date

(Italics ours.) In the course of his duties, the defendant dealt with doctors, hospitals, and physician supply companies. His sales area included Eastern Washington, Northern Idaho, and all of Montana, and he spent as much as 65 percent of his work time traveling. Therefore, Organon furnished a car for the defendant to use, and paid all of the defendant's expenses while he was away from home.

In 1973, the defendant became associated with Phone-a-Gram, a company which manufactures a machine which interprets electrocardiograms. This machine transmits a patient's heart reading via telephone to a computer in San Francisco, the computer interprets the EKG, and the results are communicated to the doctor within 5 minutes. The defendant testified that in his dealings with certain doctors as a representative of Organon, he would ask them if they were interested in acquiring a Phone-a-Gram for their office. If the doctor was interested, the defendant returned during lunch or after his usual work hours to demonstrate it. Organon was not aware of the defendant's activities on behalf of Phone-a-Gram and the defendant specifically stated that he did not tell Organon personnel about these activities because he "was not sure of their reaction." However, the defendant also maintained that he acted for Phone-a-Gram on the condition that his solicitations for that company would not interfere with his duties *435 for Organon. According to the defendant, no such interference ever developed. In fact, Organon personnel continued to regard him as an outstanding employee during the years in question.

In May 1977, Organon discovered that the defendant was acting as agent for Phone-a-Gram. The defendant's employment was immediately terminated, and the company instituted this action for breach of the Statement of Policy. At trial, the defendant's position was that the Statement of Policy was unreasonable as applied to this particular situation. He argued that Organon could not complain of his activity because Phone-a-Gram was not a competitor of Organon, and he had limited his solicitations for Phone-a-Gram to doctors whom he was already seeing for Organon. Thus, his expenses were not increased by his outside activities. In discussing a directed verdict, the trial judge was of the opinion that these facts did not affect the defendant's liability for breach of the agreement.

The trial court awarded Organon $8,019.53. It arrived at this figure by multiplying the percentage of defendant's total income attributable to Phone-a-Gram commissions by the amount Organon had reimbursed the defendant for his traveling expenses. For example, in 1974, Organon paid the defendant $7,685.17 for expenses. That same year, the defendant collected $8,588.44 from Phone-a-Gram — an amount equal to 36 percent of his total income. Therefore, the court awarded Organon 36 percent of the defendant's expenses, or $2,766.66, in damages for 1974. Damages for 1975 and 1976 were calculated in the same manner.

First, the defendant contends that the question of his liability for the alleged breach was for the jury, and that the trial court erred in directing a verdict for Organon. He argues that the jury could have found that it was unreasonable to apply the Statement of Policy to this situation, where Organon suffered no lost profits as a result of his activities on behalf of Phone-a-Gram. We disagree.

*436 No prior Washington case has construed an agreement which restricts an employee from engaging in business activities unrelated to the business of his employer. 1 Generally, the courts of other jurisdictions have refused to interpret a contract which requires an employee to devote his whole time and attention to his employment to include time normally devoted to rest and recreation. Kiker v. Bank Sav. Life Ins. Co., 37 N.M. 346, 23 P.2d 366 (1966); Durwood v. Dubinsky, 361 S.W.2d 779 (Mo. 1962); Hillsboro Nat'l Bank u. Hyde, 7 N.D. 400, 75 N.W. 781 (1898).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Emerick v. Cardiac Study Center, Inc.
286 P.3d 689 (Court of Appeals of Washington, 2012)
National City Bank, N.A. v. Prime Lending, Inc.
737 F. Supp. 2d 1257 (E.D. Washington, 2010)
Pacific Aerospace & Electronics, Inc. v. Taylor
295 F. Supp. 2d 1188 (E.D. Washington, 2003)
Kieburtz & Associates, Inc. v. Rehn
842 P.2d 985 (Court of Appeals of Washington, 1992)
Perry v. Moran
748 P.2d 224 (Washington Supreme Court, 1987)
Fahlen v. Mounsey
728 P.2d 1097 (Court of Appeals of Washington, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
595 P.2d 1314, 23 Wash. App. 432, 1979 Wash. App. LEXIS 2338, Counsel Stack Legal Research, https://law.counselstack.com/opinion/organon-inc-v-hepler-washctapp-1979.